Nova MD review

What it is

Nova MD (also branded Try Nova) is a telehealth platform selling compounded GLP-1 medication alongside a longevity and strength line: sermorelin at $149/mo month-to-month or $115/mo on the three-month plan, NAD⁺ injection at $155/mo or $124/mo, glutathione, enclomiphene 25 mg capsules and a microdosed GLP-1 program covering both semaglutide and tirzepatide. Its GLP-1 tiers run $175/mo and $125/mo for compounded semaglutide and $199/mo and $169/mo for compounded tirzepatide. Care is delivered by US-licensed physicians reviewing an online assessment, with same-day review advertised, free overnight shipping and FSA/HSA eligibility on some plans.

How it works

Asynchronous and quiz-led: a short online assessment, same-day provider review, and a prescription shipped from an unnamed partner pharmacy. Everything about the storefront is designed to be read before you commit, which is unusual — the plan cards show the monthly and the prepay rate together rather than headlining the cheaper one, and the product cards state the strength and vial size for the injectables. That is the level of detail you would otherwise have to ask for. The entity side is the opposite. No legal entity or state of incorporation is disclosed anywhere. The pharmacy is described only as an accredited facility. LegitScript certification is not claimed, only generic 'licensed US providers' and 'US pharmacies' language. No per-state availability list exists. Its patient-count claim — which has climbed from 1,241+ to 1,801+ across our checks — is unverified marketing, and the site's own cancellation language notes a $25 provider fee if you cancel after provider review but before shipping. None of that is disqualifying on its own; together it means you are trusting a well-built storefront rather than a disclosed company.

Pricing transparency

Sermorelin is $149/mo on the one-month plan and $115/mo on the three-month plan; NAD⁺ is $155/mo and $124/mo on the same two tiers. Both figures are on the homepage, both tiers shown together. Two things to check before you assume that is the whole picture. First, Nova MD's GLP-1 product pages state explicitly that price scales with dose — 'doses 4, 5, 6 and higher are $299/month' against $189/month for lower doses — so ask directly whether the peptide and NAD⁺ tiers behave the same way as a provider titrates you, because the homepage cards do not say. Second, plans are described as including consultations, dose titration and free overnight shipping, with no separate membership, but the $25 cancellation fee after provider review is a real cost if you change your mind. Lab work and ongoing monitoring are not clearly addressed anywhere.

Branded vs compounded

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Nova MD states this in its own footnotes — the FDA does not review or approve any compounded medications for safety or effectiveness — and adds that physicians may prescribe compounded medications to meet patient requirements or drug shortages. It does not name the pharmacy, and compounded sterile preparations are not reviewed by the FDA for purity and potency the way approved drugs are. On the evidence, the four molecules are not one thing. Sermorelin is a GHRH analogue acting on your own pituitary — a real, well-characterised mechanism whose long-term human outcome data stays thin. Injected NAD⁺ has no controlled human outcome trials; the oral precursors NR and NMN reliably raise blood NAD⁺, which is a biomarker rather than a demonstrated benefit, and knowing the vial is 100 mg/mL tells you what you are injecting, not whether injecting it helps. Glutathione has essentially no controlled human outcome data behind the antioxidant and skin claims made for it. Enclomiphene is the outlier: a selective oestrogen receptor modulator that raises endogenous testosterone through the hypothalamic-pituitary axis, with real clinical trial data, but it is not FDA-approved for that use and compounded enclomiphene is not an approved product. Individual results vary.

Pros and watch-outs

The evidence behind what Nova MD prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• Sermorelin: a real GHRH drug, read against the anti-aging pitch

  An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.

• NAD+ precursors (NR and NMN): what the human trials actually show

  They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.

• Glutathione: the master antioxidant, and where the evidence actually is

  Oral glutathione really does raise your body stores (a 6-month RCT proved it) — but the longevity and detox claims are unproven, skin-lightening is modest, and IV glutathione is the most marketed, least evidenced route. The precursors may be the smarter bet.

• Enclomiphene: the evidence for restoring testosterone without replacing it

  Randomized trials, including two Phase III RCTs, show enclomiphene restores a man's own testosterone while preserving fertility — but it was never FDA-approved.

How Nova MD compares

A few alternatives worth a look, depending on what you’re optimizing for.

• OHObu Health

  NAD⁺ injections from a platform that names the pharmacies preparing them

  See Obu Health →
• NKNäky

  NAD⁺ at a rate that does not climb when a provider raises your dose

  See Näky →
• NSNeo Soma Healthcare

  Reading an NAD⁺ price on a storefront rather than being quoted one after intake

  See Neo Soma Healthcare →